OnKure Therapeutics, Inc. Cash Flow Quality Index

Latest as of December 2023: 0.51x

OnKure Therapeutics, Inc. cash flow quality index. OnKure Therapeutics, Inc. (OKUR) has a Cash Flow Quality Index of 0.51x as of December 2023. Operating cash flow of $9.38 Million is below net income of $18.52 Million, suggesting accrual-heavy earnings not yet converted to cash. See OKUR financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

0.51x
Operating CF / Net Income

Operating Cash Flow

$9.38 Million
USD

Net Income

$18.52 Million
USD

Data as of

Dec 2023
Most recent filing

OnKure Therapeutics, Inc. Cash Flow Quality Index by Year (None–None)

OnKure Therapeutics, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for OnKure Therapeutics, Inc.. For the full cash flow conversion analysis, see OnKure Therapeutics, Inc. cash conversion from operations.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.